Related Experiment Videos

Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline

C W Song1, T Hasegawa, H C Kwon

  • 1University of Minnesota Medical School, Department of Therapeutic Radiology-Radiation Oncology, Minneapolis 55455.

Radiation Research
|May 1, 1992
PubMed

Insights

Pentoxifylline (PTX) increases oxygen levels in tumors, enhancing the effectiveness of radiation therapy. This study shows PTX

Area of Science:

  • Oncology
  • Pharmacology
  • Radiation Biology

Background:

  • Pentoxifylline (PTX) is a medication used for vascular disorders.
  • Tumor hypoxia (low oxygen) is a known factor limiting radiation therapy efficacy.

Purpose of the Study:

  • To investigate the effect of pentoxifylline (PTX) on tumor oxygen levels (pO2).
  • To evaluate the impact of PTX on the radioresponse of tumors.

Main Methods:

  • Administered PTX intraperitoneally to mice bearing SCK or FSa-II tumors.
  • Measured tumor pO2 at various time points after PTX injection.
  • Assessed tumor growth delay following X-irradiation after PTX administration.

Main Results:

  • PTX administration led to a transient increase in tumor pO2.
  • Higher PTX doses prolonged the elevation of tumor oxygen levels.
  • PTX combined with X-irradiation resulted in greater tumor growth delay compared to X-irradiation alone.

Conclusions:

  • Pentoxifylline (PTX) effectively increases tumor oxygenation.
  • PTX shows potential as an adjunct to radiation therapy for improving tumor radioresponse.

Related Concept Videos